NASDAQ: CBLL
Ceribell Inc Earnings Dates, Reports, Calls

Ceribell earnings were -$40.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CBLL earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$12.6M, up 20.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CBLL reported annual earnings of -$40.5M, with 37.3% growth.

CBLL earnings history

Current Revenue
$65.4M
Current Earnings
-$40.5M
Current Profit Margin
-61.8%

CBLL Return on Equity

Current Company
-102.5%
Current Industry
11.5%
Current Market
34.1%

CBLL undefined

Current Company
-28.5%
Current Industry
8%

Be the first to know when CBLL announces earnings.

CBLL undefined

Current Company
-18.11%
Current Industry
9%

CBLL vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CBLL-$37.26M-$40.46MN/A-$3.39
AVNS-$351.40M-$392.10MN/A-$8.53
BFLY-$60.92M-$72.49MN/A-$0.34
OFIX-$34.18M-$126.00MN/A-$3.30
SIBN-$23.09M-$30.91MN/A-$0.75

Ceribell Earnings Reports & History FAQ

What were Ceribell's earnings last quarter?

Ceribell (NASDAQ: CBLL) reported Q4 2024 earnings per share (EPS) of $1.63, up 205.84% year over year. Total CBLL earnings for the quarter were -$12.58 million. In the same quarter last year, Ceribell's earnings per share (EPS) was -$1.54.

If you're new to stock investing, here's how to buy Ceribell stock.

Is Ceribell profitable or losing money?

As of the last Ceribell earnings report, Ceribell is currently losing money. Ceribell's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$40.46 million, a 37.3% increase year over year.

What was CBLL's earnings growth in the past year?

As of Ceribell's earnings date in Q2 2025, Ceribell's earnings has grown year over year. CBLL earnings in the past year totalled -$40.46 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.